GONAL-F Trademark

Trademark Overview

On Friday, January 31, 1992, a trademark application was filed for GONAL-F with the United States Patent and Trademark Office. The USPTO has given the GONAL-F trademark a serial number of 74242359. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 31, 2023. This trademark is owned by Ares Trading S.A.. The GONAL-F trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation; namely, recombinant follicle stimulating hormone for medical treatment
gonal-f

General Information

Serial Number74242359
Word MarkGONAL-F
Filing DateFriday, January 31, 1992
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 31, 2023
Registration Number1772761
Registration DateTuesday, May 25, 1993
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 2, 1993

Trademark Statements

Goods and Servicespharmaceutical preparation; namely, recombinant follicle stimulating hormone for medical treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 3, 1992
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK KGAA
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressDARMSTADT 64293
DE
Party NameAres Trading S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAubonne CH-1170
CH
Party NameAres Trading S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address2028 Vaumarcus
CH
Party NameAres Trading S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address2028 Vaumarcus
CH

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, October 31, 2023REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Tuesday, October 31, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 31, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 5, 2023TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 25, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 18, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 18, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 7, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, June 7, 2013REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, June 7, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, June 6, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 13, 2013TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 24, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 13, 2009CASE FILE IN TICRS
Tuesday, October 19, 2004TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 20, 2003REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, August 20, 2003REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 30, 2003REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, May 30, 2003PAPER RECEIVED
Friday, September 24, 1999REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 24, 1999REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, May 25, 1993REGISTERED-PRINCIPAL REGISTER
Tuesday, March 2, 1993PUBLISHED FOR OPPOSITION
Friday, January 29, 1993NOTICE OF PUBLICATION
Wednesday, September 30, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 17, 1992CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 11, 1992NON-FINAL ACTION MAILED
Wednesday, April 8, 1992ASSIGNED TO EXAMINER

Related Keywords

gonal hormone medical treatment stimulating follicle preparation namely recombinant pharmaceutical